Emami Ltd
Emami Ltd
Fast Moving Consumer GoodsEmami is engaged in manufacturing & marketing of personal care & healthcare products with an enviable portfolio of household brand names such as BoroPlus, Navratna, Fair and Handsome, Zandu Balm, Kesh King, Zandu Pancharishta, Mentho Plus Balm and others.(Source : 201903 Annual Report Page No: 193)
Emami Ltd offers strong ROE of 29% and a near debt-free balance sheet, but stock CAGR of -25% over 1 year and tepid sales growth of 4% over 3 years suggest limited near-term upside. At a PE of 22.5x with flat TTM revenue growth of -1%, the valuation lacks a margin of safety for new entry.
Key Fundamentals
SmallcapPersonal CareConsumer GoodsTechnical Indicators
Key Insights
Strengths
4- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 29.3%
- Company has been maintaining a healthy dividend payout of 45.4%
- Debtor days have improved from 42.3 to 33.2 days.
Weaknesses
3- The company has delivered a poor sales growth of 5.58% over past five years.
- Tax rate seems low
- Working capital days have increased from 40.4 days to 66.3 days
Growth Rate
AI Analysis — Bull vs Bear
Emami Ltd offers strong ROE of 29% and a near debt-free balance sheet, but stock CAGR of -25% over 1 year and tepid sales growth of 4% over 3 years suggest limited near-term upside. At a PE of 22.5x with flat TTM revenue growth of -1%, the valuation lacks a margin of safety for new entry.
- Company is virtually debt-free, providing financial flexibility and resilience during economic downturns
- 3-year ROE of 29% demonstrates consistently high capital efficiency well above FMCG sector median of ~18-20%
- Compounded profit growth of 13% over 5 years outpaces sales growth of 6%, indicating improving operating leverage and margin expansion
- Healthy dividend payout of 45.4% with current yield of 2.5% offers income support in a weak stock price environment
- 73.9% analyst buy ratings (17 out of 23 analysts) with zero sell ratings signals strong Street consensus on recovery potential
- Debtor days improved from 42.3 to 33.2 days, reflecting better receivables management and cash conversion
- 10-year compounded profit growth of 7% with last-year ROE at 28% shows the business model remains fundamentally profitable
- Market cap of Rs 17,811 Cr positions Emami as a mid-cap FMCG player with potential re-rating opportunity if growth accelerates
- Stock CAGR of -25% over 1 year and -5% over 5 years indicates persistent value destruction for shareholders
- TTM sales growth of -1% signals revenue stagnation and possible market share loss in key categories
- Working capital days deteriorated significantly from 40.4 to 66.3 days, a 64% increase indicating operational inefficiency
- 5-year sales CAGR of only 5.58% is well below FMCG sector leaders growing at 10-15% annually
- PE of 22.5x is expensive relative to near-zero TTM earnings growth of just 1%, implying a PEG ratio above 22x
- 10-year stock CAGR of -3% means the stock has delivered negative real returns over a full market cycle
- Price-to-book of 5.98x is elevated for a company with flat top-line growth, limiting downside protection
- Low reported tax rate raises questions about sustainability of earnings quality and future effective tax normalization risk
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- IncNut Digital majority stake acquired Jun 1
Emami completed acquisition of 59.69% stake in IncNut Digital on June 1, 2026 via 2,05,767 equity shares, making it a subsidiary.
- IncNut stake raised to 60% Jun 12
Emami acquired 1,064 additional shares on June 11, 2026, increasing its IncNut Digital holding from 59.69% to 60.00%.
- Rs 33.57 Cr block trade on NSE Jun 23
Block trade of ~8,40,360 shares executed at Rs 399.50/share on NSE, totalling Rs 33.57 crores, indicating institutional-level participation.
- Rs 20.27 Cr block trade on NSE May 29
Block trade of ~5,05,692 shares at Rs 400.75/share on NSE, totalling Rs 20.27 crores, suggesting institutional activity.
- Promoters pledge and release shares Jun 9
Promoters Diwakar Finvest and Suraj Finvest adjusted share pledges with changes reported to exchanges on June 8, 2026.
- Promoters pledge shares with lenders May 30
Diwakar Finvest and Suraj Finvest pledged shares worth 0.27% and 0.23% respectively with Bajaj Finance and HSBC InvestDirect.
TL;DR: Emami is actively pursuing inorganic growth with the IncNut Digital acquisition, signalling intent to expand its digital and D2C presence. No material headwinds emerged in the recent news cycle. Promoter pledge activity remains at low levels and block trades suggest steady institutional interest around the Rs 400 mark. The near-term outlook is stable with potential upside from the IncNut integration delivering on digital strategy.
Quarterly Results
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 836 | 826 | 865 | 996 | 891 | 906 | 891 | 1,049 | 963 | 904 | 799 | 1,152 | 925 |
| Expenses | 636 | 636 | 632 | 682 | 682 | 692 | 645 | 715 | 744 | 692 | 622 | 768 | 739 |
| Operating Profit | 199 | 190 | 233 | 314 | 209 | 214 | 246 | 334 | 219 | 212 | 177 | 384 | 186 |
| OPM % | 24% | 23% | 27% | 32% | 24% | 24% | 28% | 32% | 23% | 23% | 22% | 33% | 20% |
| Other Income | 14 | 8 | 11 | 11 | 11 | 10 | 22 | 15 | 21 | 22 | 21 | 9 | 23 |
| Interest | 1 | 2 | 2 | 3 | 3 | 2 | 2 | 2 | 3 | 2 | 3 | 3 | 3 |
| Depreciation | 64 | 46 | 46 | 46 | 48 | 44 | 45 | 46 | 44 | 44 | 45 | 45 | 42 |
| PBT | 148 | 150 | 196 | 276 | 169 | 178 | 220 | 301 | 194 | 187 | 150 | 345 | 164 |
| Tax % | 4% | 9% | 8% | 6% | 13% | 16% | 4% | 7% | 16% | 12% | 1% | 7% | 13% |
| Net Profit | 142 | 137 | 180 | 261 | 147 | 151 | 211 | 279 | 162 | 164 | 148 | 319 | 143 |
| EPS in Rs | 3.27 | 3.14 | 4.09 | 5.92 | 3.41 | 3.5 | 4.87 | 6.39 | 3.72 | 3.76 | 3.4 | 7.32 | 3.28 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,076 | 2,358 | 2,488 | 2,531 | 2,695 | 2,655 | 2,881 | 3,192 | 3,406 | 3,578 | 3,809 | 3,780 |
| Expenses | 1,536 | 1,670 | 1,729 | 1,812 | 1,970 | 1,970 | 2,000 | 2,254 | 2,550 | 2,632 | 2,796 | 2,820 |
| Operating Profit | 541 | 688 | 759 | 719 | 725 | 685 | 880 | 938 | 855 | 946 | 1,014 | 960 |
| OPM % | 26% | 29% | 31% | 28% | 27% | 26% | 31% | 29% | 25% | 26% | 27% | 25% |
| Other Income | 91 | 44 | 31 | 19 | 25 | 46 | 69 | 90 | 69 | 41 | 68 | 75 |
| Interest | 5 | 54 | 58 | 34 | 21 | 21 | 13 | 5 | 7 | 10 | 9 | 11 |
| Depreciation | 34 | 255 | 309 | 311 | 325 | 336 | 367 | 335 | 247 | 186 | 178 | 177 |
| PBT | 592 | 423 | 424 | 393 | 403 | 374 | 569 | 688 | 670 | 791 | 894 | 846 |
| Tax % | 18% | 14% | 20% | 22% | 25% | 19% | 20% | -22% | 6% | 8% | 10% | 8% |
| Net Profit | 485 | 363 | 340 | 306 | 303 | 302 | 455 | 837 | 627 | 724 | 803 | 775 |
| EPS in Rs | 10.7 | 8 | 7.5 | 6.77 | 6.68 | 6.67 | 10.23 | 19.02 | 14.5 | 16.58 | 18.48 | 17.76 |
| Div. Payout % | 33% | 44% | 47% | 52% | 60% | 60% | 78% | 42% | 55% | 48% | 54% | 34% |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 23 | 23 | 23 | 23 | 45 | 45 | 44 | 44 | 44 | 44 | 44 | 44 |
| Reserves | 1,208 | 1,589 | 1,732 | 1,991 | 2,031 | 1,778 | 1,718 | 2,032 | 2,259 | 2,403 | 2,651 | 2,880 |
| Borrowings | 36 | 671 | 473 | 326 | 110 | 210 | 101 | 282 | 91 | 94 | 90 | 162 |
| Other Liabilities | 410 | 409 | 376 | 458 | 633 | 644 | 656 | 692 | 703 | 728 | 741 | 751 |
| Total Liabilities | 1,676 | 2,692 | 2,603 | 2,798 | 2,819 | 2,678 | 2,520 | 3,050 | 3,096 | 3,269 | 3,525 | 3,836 |
| Fixed Assets | 453 | 1,918 | 1,994 | 1,802 | 1,680 | 1,459 | 1,132 | 1,344 | 1,245 | 1,114 | 984 | 887 |
| CWIP | 29 | 67 | 22 | 30 | 36 | 8 | 6 | 3 | 6 | 8 | 15 | 1 |
| Investments | 501 | 104 | 128 | 314 | 187 | 156 | 255 | 303 | 293 | 442 | 676 | 834 |
| Other Assets | 693 | 604 | 460 | 652 | 915 | 1,055 | 1,126 | 1,400 | 1,551 | 1,706 | 1,850 | 2,114 |
| Total Assets | 1,676 | 2,692 | 2,603 | 2,798 | 2,819 | 2,678 | 2,520 | 3,050 | 3,096 | 3,269 | 3,525 | 3,836 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 534 | 562 | 730 | 588 | 554 | 531 | 922 | 644 | 749 | 779 | 896 | 801 |
| Investing | -237 | -1,313 | -306 | -276 | -26 | -231 | -224 | -234 | -122 | -210 | -345 | -181 |
| Financing | -215 | 502 | -496 | -324 | -428 | -405 | -688 | -402 | -608 | -563 | -500 | -554 |
| Net Cash Flow | 82 | -249 | -72 | -12 | 100 | -106 | 9 | 8 | 19 | 6 | 52 | 65 |
| Free Cash Flow | 426 | 430 | 448 | 465 | 421 | 383 | 890 | 164 | 719 | 750 | 852 | 770 |
| CFO/OP | 116 | 96 | 105 | 93 | 89 | 89 | 115 | 84 | 101 | 98 | 107 | 101 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 18 | 20 | 14 | 22 | 29 | 42 | 29 | 37 | 44 | 50 | 43 | 33 |
| Inventory Days | 59 | 68 | 83 | 87 | 88 | 102 | 118 | 121 | 100 | 102 | 94 | 128 |
| Days Payable | 90 | 112 | 85 | 109 | 115 | 135 | 138 | 138 | 124 | 143 | 133 | 153 |
| Cash Conversion Cycle | -13 | -24 | 12 | 1 | 2 | 9 | 10 | 19 | 20 | 9 | 4 | 8 |
| Working Capital Days | -16 | -54 | -62 | -32 | -6 | 7 | -3 | 0 | 28 | 30 | 25 | 66 |
| ROCE % | 61% | 30% | 23% | 22% | 19% | 18% | 29% | 31% | 28% | 32% | 32% | 30% |
Documents
Frequently Asked Questions about Emami Ltd
What does Emami Ltd do?
Where is Emami Ltd (EMAMILTD) listed?
Which sector does Emami Ltd belong to?
What is the market capitalisation of Emami Ltd?
What is the PE ratio of Emami Ltd?
What is the 52-week high and low of Emami Ltd?
Does Emami Ltd pay dividends?
What is the Return on Equity (ROE) of Emami Ltd?
How can I research Emami Ltd on Tapetide?
Company Information
Emami is engaged in manufacturing & marketing of personal care & healthcare products with an enviable portfolio of household brand names such as BoroPlus, Navratna, Fair and Handsome, Zandu Balm, Kesh King, Zandu Pancharishta, Mentho Plus Balm and others.(Source : 201903 Annual Report Page No: 193)